202 related articles for article (PubMed ID: 23343909)
1. Incident tuberculosis and risk factors among HIV-infected children in Tanzania.
Li N; Manji KP; Spiegelman D; Muya A; Mwiru RS; Liu E; Chalamilla G; Fawzi WW; Duggan C
AIDS; 2013 May; 27(8):1273-81. PubMed ID: 23343909
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy.
Liu E; Makubi A; Drain P; Spiegelman D; Sando D; Li N; Chalamilla G; Sudfeld CR; Hertzmark E; Fawzi WW
AIDS; 2015 Jul; 29(11):1391-9. PubMed ID: 26091295
[TBL] [Abstract][Full Text] [Related]
3. The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.
Braitstein P; Nyandiko W; Vreeman R; Wools-Kaloustian K; Sang E; Musick B; Sidle J; Yiannoutsos C; Ayaya S; Carter EJ
Pediatr Infect Dis J; 2009 Jul; 28(7):626-32. PubMed ID: 19451858
[TBL] [Abstract][Full Text] [Related]
4. Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study.
Sabasaba A; Mwambi H; Somi G; Ramadhani A; Mahande MJ
BMC Infect Dis; 2019 Jan; 19(1):62. PubMed ID: 30654753
[TBL] [Abstract][Full Text] [Related]
5. Tuberculosis among HIV-infected population: incidence and risk factors in rural Tanzania.
Said K; Verver S; Kalingonji A; Lwilla F; Mkopi A; Charalambous S; Reither K
Afr Health Sci; 2017 Mar; 17(1):208-215. PubMed ID: 29026395
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.
Nagu TJ; Aboud S; Mwiru R; Matee MI; Rao M; Fawzi WW; Zumla A; Maeurer MJ; Mugusi F
Int J Infect Dis; 2017 Mar; 56():39-44. PubMed ID: 28161460
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
Crook AM; Turkova A; Musiime V; Bwakura-Dangarembizi M; Bakeera-Kitaka S; Nahirya-Ntege P; Thomason M; Mugyenyi P; Musoke P; Kekitiinwa A; Munderi P; Nathoo K; Prendergast AJ; Walker AS; Gibb DM;
BMC Med; 2016 Mar; 14():50. PubMed ID: 27004529
[TBL] [Abstract][Full Text] [Related]
8. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-Echevarría A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis in human immunodeficiency virus infected Ugandan children starting on antiretroviral therapy.
Bakeera-Kitaka S; Conesa-Botella A; Dhabangi A; Maganda A; Kekitiinwa A; Colebunders R; Boulware DR
Int J Tuberc Lung Dis; 2011 Aug; 15(8):1082-6. PubMed ID: 21740672
[TBL] [Abstract][Full Text] [Related]
10. Impact of expanded antiretroviral use on incidence and prevalence of tuberculosis in children with HIV in Kenya.
Abuogi LL; Mwachari C; Leslie HH; Shade SB; Otieno J; Yienya N; Sanguli L; Amukoye E; Cohen CR
Int J Tuberc Lung Dis; 2013 Oct; 17(10):1291-7. PubMed ID: 24025380
[TBL] [Abstract][Full Text] [Related]
11. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.
Hafkin J; Modongo C; Newcomb C; Lowenthal E; MacGregor RR; Steenhoff AP; Friedman H; Bisson GP
Int J Tuberc Lung Dis; 2013 Mar; 17(3):348-53. PubMed ID: 23321297
[TBL] [Abstract][Full Text] [Related]
12. Incidence and associated factors of pulmonary tuberculosis in HIV-infected children after highly active antiretroviral therapy (HAART) in China: a retrospective study.
Mu W; Zhao Y; Sun X; Ma Y; Yu L; Liu X; Zhao D; Dou Z; Fang H; Zhang F
AIDS Care; 2014; 26(9):1127-35. PubMed ID: 24512621
[TBL] [Abstract][Full Text] [Related]
13. Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade.
Wolday D; Kebede Y; Legesse D; Siraj DS; McBride JA; Kirsch MJ; Striker R
PLoS One; 2020; 15(5):e0233049. PubMed ID: 32442166
[TBL] [Abstract][Full Text] [Related]
14. Monocyte-to-Lymphocyte Ratio Is Associated With Tuberculosis Disease and Declines With Anti-TB Treatment in HIV-Infected Children.
Choudhary RK; Wall KM; Njuguna I; Pavlinac PB; LaCourse SM; Otieno V; Gatimu J; Stern J; Maleche-Obimbo E; Wamalwa D; John-Stewart G; Cranmer LM
J Acquir Immune Defic Syndr; 2019 Feb; 80(2):174-181. PubMed ID: 30399036
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis in HIV-infected Tanzanian children below 14 years.
Njau JC; Aboud S
East Afr J Public Health; 2010 Sep; 7(3):199-205. PubMed ID: 21516954
[TBL] [Abstract][Full Text] [Related]
16. HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort.
Martinson NA; Moultrie H; van Niekerk R; Barry G; Coovadia A; Cotton M; Violari A; Gray GE; Chaisson RE; McIntyre JA; Meyers T
Int J Tuberc Lung Dis; 2009 Jul; 13(7):862-7. PubMed ID: 19555536
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for mortality in Malawian children with human immunodeficiency virus and tuberculosis co-infection.
Buck WC; Olson D; Kabue MM; Ahmed S; Nchama LK; Munthali A; Hosseinipour MC; Kazembe PN
Int J Tuberc Lung Dis; 2013 Nov; 17(11):1389-95. PubMed ID: 24125439
[TBL] [Abstract][Full Text] [Related]
18. Incidence and predictors of tuberculosis among HIV-positive children at Adama Referral Hospital and Medical College, Oromia, Ethiopia: a retrospective follow-up study.
Beshir MT; Beyene AH; Tlaye KG; Demelew TM
Epidemiol Health; 2019; 41():e2019028. PubMed ID: 31319659
[TBL] [Abstract][Full Text] [Related]
19. Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041.
Zeldow B; Kim S; McSherry G; Cotton MF; Jean-Philippe P; Violari A; Bobat R; Nachman S; Mofenson LM; Madhi SA; Mitchell C
Int J Tuberc Lung Dis; 2017 Jan; 21(1):38-45. PubMed ID: 28157463
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis in human immunodeficiency virus-infected children starting antiretroviral therapy in Côte d'Ivoire.
Auld AF; Tuho MZ; Ekra KA; Kouakou J; Shiraishi RW; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
Int J Tuberc Lung Dis; 2014 Apr; 18(4):381-7. PubMed ID: 24670690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
